1. Kew, M. C. Aflatoxins as a cause of hepatocellular carcinoma. J Gastrointestin Liver Dis. 22, 305–310 (2013).
2. Bosch, F. X. & Munoz, N. Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions. IARC scientific publications. 427–438 (1988).
3. Wild, C. P. & Turner, P. C. The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis. 17, 471–481 (2002).
4. Kamdem, L. K., Meineke, I., Godtel-Armbrust, U., Brockmoller, J. & Wojnowski, L. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1. Chemical research in toxicology. 19, 577–586 (2006).
5. Gallagher, E. P., Wienkers, L. C., Stapleton, P. L., Kunze, K. L. & Eaton, D. L. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Cancer research. 54, 101–108 (1994).